advertisement
Park KH 35
Showing records 1 to 25 | Display all abstracts from Park KH71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Lerner SF
Journal of Ophthalmology 2017; 2017: 1917570
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Park CG
International Journal of Pharmaceutics 2017; 522: 66-73
71301 Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Lee JY
Current Eye Research 2017; 0: 1-6
71115 Vision-related Quality of Life in Korean Glaucoma Patients
Sung KR
Journal of Glaucoma 2017; 26: 159-165
71118 Inferior Macular Damage in Glaucoma: Its Relationship to Retinal Nerve Fiber Layer Defect in Macular Vulnerability Zone
Kim YK
Journal of Glaucoma 2017; 26: 126-132
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim YK
International Journal of Pharmaceutics 2017; 522: 66-73
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Park KH
Journal of Ophthalmology 2017; 2017: 1917570
71301 Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Kim JM
Current Eye Research 2017; 0: 1-6
71118 Inferior Macular Damage in Glaucoma: Its Relationship to Retinal Nerve Fiber Layer Defect in Macular Vulnerability Zone
Jeoung JW
Journal of Glaucoma 2017; 26: 126-132
71115 Vision-related Quality of Life in Korean Glaucoma Patients
Chun YS
Journal of Glaucoma 2017; 26: 159-165
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Hubatsch DA
Journal of Ophthalmology 2017; 2017: 1917570
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Kim SN
International Journal of Pharmaceutics 2017; 522: 66-73
71118 Inferior Macular Damage in Glaucoma: Its Relationship to Retinal Nerve Fiber Layer Defect in Macular Vulnerability Zone
Park KH
Journal of Glaucoma 2017; 26: 126-132
71115 Vision-related Quality of Life in Korean Glaucoma Patients
Park CK
Journal of Glaucoma 2017; 26: 159-165
71301 Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Kim IT
Current Eye Research 2017; 0: 1-6
71115 Vision-related Quality of Life in Korean Glaucoma Patients
Kim HK
Journal of Glaucoma 2017; 26: 159-165
71301 Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Yoo CK
Current Eye Research 2017; 0: 1-6
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Erichev V
Journal of Ophthalmology 2017; 2017: 1917570
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Lee SH
International Journal of Pharmaceutics 2017; 522: 66-73
71301 Relationship between Plasma Homocysteine Level and Glaucomatous Retinal Nerve Fiber Layer Defect
Won YS
Current Eye Research 2017; 0: 1-6
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Paczka JA
Journal of Ophthalmology 2017; 2017: 1917570
71115 Vision-related Quality of Life in Korean Glaucoma Patients
Yoo C
Journal of Glaucoma 2017; 26: 159-165
71526 Enhanced Ocular Efficacy of Topically-delivered Dorzolamide with Nanostructured Mucoadhesive Microparticles
Huh BK
International Journal of Pharmaceutics 2017; 522: 66-73
71115 Vision-related Quality of Life in Korean Glaucoma Patients
Kim YY
Journal of Glaucoma 2017; 26: 159-165
71578 Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
Roberts TV
Journal of Ophthalmology 2017; 2017: 1917570
